Resistent tuberkulose i Danmark

Ugeskrift for Laeger

Volumn 163, Issue 13, 2001, Pages 1842-1846

  Thomsen, Vibeke Østergaard ^a   Johansen, Isik Somuncu ^a   Bauer, Jeanett Østerby ^a   Glismann, Steffen Offersen ^a   Lillebœk, Troels ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DENMARK; DNA FINGERPRINTING; DRUG EFFECT; ETHNOLOGY; GENETICS; HUMAN; IMMUNOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; DENMARK; DNA FINGERPRINTING; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0035953260     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991; 40: 585-91.
2. Centers for Disease Control and Prevention. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. MMWR Morb Mortal Wkly Rep 1992; 41: 507-9.
3. Coronado VG, Beck Sague CM, Hutton MD, Davis BJ, Nicholas P, Villareal C et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993; 168: 1052-5.
4. Samper S, Martin C, Pinedo A, Rivero A, Blazquez J, Baquero F et al. Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS 1997; 11: 1237-42.
5. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 1997; 24 (Suppl 1): S121-30.
6. Manalo F, Tan F, Sbarbaro JA, Iseman MD. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Am Rev Respir Dis 1990; 142: 1301-5.
7. Hong Kong Tuberculosis Treatment Services - British Medical Research Council Investigation. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1972; 106: 1-22.
8. WHO Geneva/IUATLD Paris. Guidelines for surveillance of drug resistance in tuberculosis. Int J Tuberc Lung Dis 1998; 2: 72-89.
9. WHO.Anti-Tuberculosis Drug Resistance in the World. Report No. 2, 2000
10. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
11. Heersma H, Kremer K, van Embden JDA. Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. Methods Mol Biol 1998; 101: 395-422.
12. Bauer, J. Molecular epidemiology studies of the Mycobacterium tuberculosis complex and the Mycobacterium avium complex. [ph.d.-afhandling]. København: Department of Mycobacteriology, Statens Serum Institut, 1999.
13. Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.
14. Lillebæk T, Andersen ÅB, Bauer J, Dirksen A, Glismann S, de Haas P, Kok-Jensen A. The risk of Mycobacterium tuberculosis transmission in a low incidence country due to immigration from high incidence areas. J Clin Microbiol 2001; 39: 855-61.